Why Walgreens is shuttering 1,200 stores while pharma sales soar to $722 billion | Yahoo Finance
Excerpt from Yahoo Finance: “Walgreens is pulling the plug on 1,200 stores over the next three years. That’s no small cut. And they’re not the only ones feeling the squeeze. Business Insider reported that CVS and Rite Aid are scaling back too.” Read more.
2024 FDA approvals | Nature
Excerpt from Nature: “The FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new small molecules, biologics and oligonucleotide therapeutics last year. The class of 2024 was a little smaller than that of 2023, which had 55 approvals and was the second largest in the past 30 years. The 10-year rolling average now stands at 46.5 novel approvals per year, a new high-water mark.” Read more.
Novo Nordisk pushes FDA to exclude compounding for its early-generation diabetes drug | Yahoo Finance
Excerpt from Yahoo Finance: “In December, Danish pharmaceutical giant Novo Nordisk A/S submitted a Citizen Petition to the FDA requesting the exclusion of liraglutide from the 503B Bulks List, a registry of substances that outsourcing facilities may use in drug compounding.” Read more.
Sorry, the comment form is closed at this time.